People treated with ranibizumab for edema due to retinal vein occlusion as part of previous studies at the Wilmer Eye Institute and who are currently being seen by their ophthalmologist at the Wilmer Eye Institute are followed up to assess long term outcomes
This research is being done to assess the long term prognosis of patients treated with ranibizumab for edema due to retinal vein occlusion.